LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through Commercialization Boca Raton, Florida, July 27, 2020 – LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The[…]
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
LGM Pharma, Press Release Tags: growth Jul 23, 2020
LGM Pharma Expands Client Service Offerings Supporting The Provision of High Quality Active Pharmaceutical Ingredients (APIs) For 503B Outsourcing Facilities
Press Release Tags: 503B503B-partnerCGMP-requirementscompounding-APIsdocumentationFDA-complianceFDCA-compliancegrowthimportationlabelingmanufacturersmarket-intelligenceNDA-requirementspack-sizesvalue-added-serviceswillowbirch Jun 23, 2019
Erlanger, Kentucky, June 24, 2019 – LGM Pharma, LLC, a leader in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management to the pharmaceutical and biotechnology industries, today reported that it is offering an expanded set of value-added services to support its clients who supply APIs to compounding pharmacies under section 503B of the[…]
ORPHANION Partners with API Sourcing Leader LGM Pharma to Expand Global Access to Its Niche API Services
LGM Pharma, Press Release Tags: CMOCRAMSCROgrowthORPHANIONPartnership Mar 18, 2019
March 18, 2019, Basel, Switzerland and Erlanger, Kentucky, USA – Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, LLC, a leader in API sourcing, warehousing and distribution services to the pharmaceutical and biotechnology industries, today announced that they have finalized a partnering[…]
Hamilton Lenox Joins LGM Pharma as Senior VP of Business Development
LGM Pharma, Press Release Tags: business developmentgrowthHamilton J. LenoxHamilton Lenox Feb 07, 2019
ERLANGER, Kentucky / BOCA RATON, Florida — LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Hamilton J. Lenox as Senior Vice President of Business Development at the Boca Raton, Florida location. In this capacity, Mr. Lenox will[…]
ERLANGER, Kentucky / Boca Raton, Florida—LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New York and Israel recently announced that Dr. Prasad S. Raje, Ph.D. would be joining the organization as the company CEO. In that capacity, Dr. Raje will be heading up all company management[…]
LGM Pharma Acquires Compounding Business Division From Zeta
LGM Pharma, Press Release Tags: growth Mar 16, 2018
Erlanger, KY / Boca Raton, FL – LGM Pharma LLC today completed the acquisition of Zeta Pharmaceuticals’ compounding business. In Q4 2017, LGM received a significant growth capital investment from private equity firm, New Harbor Capital in Chicago. The acquisition of Zeta’s compounding business is a part of LGM’s strategy to invest in expanding its[…]
New Harbor Capital Acquires Majority Interest in LGM Pharma
LGM Pharma, Press Release Tags: Gideon SchurdergrowthMendy SchurderNew Harbor Capital Nov 21, 2017
Chicago-based private equity firm New Harbor Capital completed a majority equity investment in LGM Pharma, an innovation-driven company involved in distribution of cGMP active pharmaceutical ingredients (“API”) and other value-added services supporting leading pharmaceutical companies. LGM specializes in streamlining the API supply chain throughout all development stages while providing complete technical capabilities and expert regulatory[…]